+Compare
LAB
Stock ticker:
NASDAQ
AS OF
Jul 1 closing price
Price
$1.59
Change
-$0.01 (-0.62%)
Capitalization
122.83M

LAB Price Prediction, Standard BioTools AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jul 01, 2022

LAB's Indicator enters downward trend

The Aroon Indicator for LAB entered a downward trend on July 01, 2022. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 203 similar instances where the Aroon Indicator formed such a pattern. In 186 of the 203 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 29, 2022. You may want to consider selling the stock, shorting the stock, or exploring put options on LAB as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for LAB just turned positive on June 02, 2022. Looking at past instances where LAB's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where LAB advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .

LAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.556) is normal, around the industry mean (6.885). P/E Ratio (0.000) is within average values for comparable stocks, (92.096). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.201). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (0.977) is also within normal values, averaging (79.458).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. LAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

LAB is expected to report earnings to fall 86.87% to -12 cents per share on August 04

Standard BioTools LAB Stock Earnings Reports
Q2'22
Est.
$-0.13
Q1'22
Missed
by $0.84
Q4'21
Beat
by $0.16
The last earnings report on May 05 showed earnings per share of -99 cents, missing the estimate of -15 cents. With 884.75K shares outstanding, the current market capitalization sits at 122.83M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Edwards Lifesciences Corp (NYSE:EW), Boston Scientific Corp (NYSE:BSX), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 5.74B. The market cap for tickers in the group ranges from 775 to 3.72T. MKYSF holds the highest valuation in this group at 3.72T. The lowest valued company is BIIO at 775.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -1%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -26%. HTGM experienced the highest price growth at 98%, while ABMT experienced the biggest fall at -77%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -68%. For the same stocks of the Industry, the average monthly volume growth was -34% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 71
SMR Rating: 67
Profit Risk Rating: 84
Seasonality Score: -3 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a manufacturer of integrated fluidic circuit systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2 Tower Place
Phone
+1 650 266-6000
Employees
615
Web
https://www.fluidigm.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXTTF0.040.01
+15.76%
Lifeist Wellness
TAKOF0.500.05
+11.66%
Drone Delivery CDA Corp
ACLLF34.28N/A
N/A
Atco Ltd
ACGBY9.41-0.05
-0.53%
Agricultural Bank of China Unsponsored
SOTGY161.51-2.89
-1.76%
Sunny Optical Technology Group Co Ltd

LAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, LAB has been loosely correlated with TELA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LAB jumps, then TELA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LAB
1D Price
Change %
LAB100%
-0.62%
TELA - LAB
38%
Loosely correlated
+4.99%
GTH - LAB
35%
Loosely correlated
-1.18%
BFLY - LAB
35%
Loosely correlated
-2.61%
BRKR - LAB
31%
Poorly correlated
+1.24%
BNR - LAB
31%
Poorly correlated
-8.59%
More